In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity-Reference-Cited by-同舟云学术

In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity

Published:2020-02-27 Issue:8 Volume:7 Page:1902802
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Xu Ziyang¹²,Wise Megan C.³,Chokkalingam Neethu¹,Walker Susanne¹,Tello‐Ruiz Edgar¹,Elliott Sarah T. C.¹,Perales‐Puchalt Alfredo¹,Xiao Peng¹,Zhu Xizhou¹,Pumroy Ruth A.²,Fisher Paul D.³,Schultheis Katherine³,Schade Eric³,Menis Sergey⁴⁵⁶,Guzman Stacy¹,Andersen Hanne⁷,Broderick Kate E.³,Humeau Laurent M.³,Muthumani Kar¹,Moiseenkova‐Bell Vera²,Schief William R.⁴⁵⁶⁸,Weiner David B.¹,Kulp Daniel W.¹⁹^ORCID

Affiliation:

1. The Vaccine and Immunotherapy Center The Wistar Institute Philadelphia PA 19104 USA

2. Department of Pharmacology Perelman School of Medicine University of Pennsylvania Philadelphia PA 19104 USA

3. Inovio Pharmaceuticals Plymouth Meeting Philadelphia PA 19422 USA

4. Department of Immunology and Microbiology The Scripps Research Institute La Jolla CA 92037 USA

5. IAVI Neutralizing Antibody Center The Scripps Research Institute La Jolla CA 92037 USA

6. Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery The Scripps Research Institute La Jolla CA 92037 USA

7. Bioqual Rockville MD 20852 USA

8. Ragon Institute of MGH MIT and Harvard Cambridge MA 02139 USA

9. Department of Microbiology Perelman School of Medicine University of Pennsylvania Philadelphia PA 19104 USA

Funder

W. W. Smith Charitable Trust

Norges Idrettshøgskole

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201902802

Reference69 articles.

1. Influenza Vaccines for the Future

2. Advances in HIV-1 Vaccine Development

3. History of vaccination

4. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

5. Vaccine delivery using nanoparticles

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growing Glycans in Rosetta: Accurate de novo glycan modeling, density fitting, and rational sequon design;PLOS Computational Biology;2024-06-24

2. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment;Signal Transduction and Targeted Therapy;2024-02-21

3. Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models;Human Vaccines & Immunotherapeutics;2023-11-27

4. Chicken dendritic cell-targeting nanobodies mediated improved protective effects against H9N2 influenza virus challenge in a homologous sequential immunization study;Veterinary Microbiology;2023-10

5. Mosaic Vaccine Design Targeting Mutational Spike Protein of SARS-COV-2 : an Immunoinformatics Approaches;BioImpacts;2023-07-19